ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO, INC. -- SCHEDULE 13G

Company

Gossamer Bio, Inc.

Filed

February 13, 2020

Accession Number

0001072613-20-000101

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →